Logo: to the web site of Uppsala University

uu.sePublikasjoner fra Uppsala universitet
Endre søk
Link to record
Permanent link

Direct link
Alternativa namn
Publikasjoner (10 av 71) Visa alla publikasjoner
Webb, D.-L., Hage, C., Ljung-Faxén, U., Pironti, G., Thorvaldsen, T., Andersson, D. C., . . . Hellström, P. M. (2026). Post-prandial acyl ghrelin infusion in heart failure patients increases gastric emptying rate. Naunyn-Schmiedeberg's Archives of Pharmacology, 399, 13437-13443
Åpne denne publikasjonen i ny fane eller vindu >>Post-prandial acyl ghrelin infusion in heart failure patients increases gastric emptying rate
Vise andre…
2026 (engelsk)Inngår i: Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, E-ISSN 1432-1912, Vol. 399, s. 13437-13443Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Acyl ghrelin increases cardiac output (CO) and contractility in patients with heart failure with reduced ejection fraction (HFrEF). In healthy humans, acyl ghrelin increases gastric emptying rate (GER) and hunger, a potential add-on benefit for HFrEF patients suffering from cachexia with symptoms of delayed gastric emptying and loss of appetite. The aim of this study was to determine if post-prandial acyl ghrelin infusion increases GER and hunger in HFrEF patients compared to CO. HFrEF patients (n = 29) arrived fasted and received a 500-kcal breakfast followed by 1.5 g paracetamol. They next received placebo (vehicle, n = 15) or acyl ghrelin infusion (0.1 μg/kg/min, n = 14) for 120 min. Blood was tapped for plasma at 0, 30, 60, 120, and 150 min into the meal. Hunger scores and CO were recorded. Plasma paracetamol was measured to assess GER. Paracetamol concentration peaked at 30 min in 8 of 14 (57%) in the treatment group versus 1 of 15 (7%) in the placebo group (Mann-Whitney test, P = 0.004). Remaining patients peaked at later time points. The acyl ghrelin treatment group data was segregated into rapid (peak at 30 min, n = 8) and slow (peak > 30 min, n = 6) GER sub-groups. The rapid sub-group had an acyl ghrelin treatment effect on CO (one-way repeat measures, P < 0.001) and the highest median increase in hunger across all time points. Acyl ghrelin increases GER and in tandem with increasing CO. Effects on hunger are more difficult to resolve due to variability in subjective scores. Some HFrEF patients may benefit from this add-on effect.

sted, utgiver, år, opplag, sider
Springer Nature, 2026
Emneord
Ghrelin, Heart failure, Gastroparesis, Gastric emptying, Acetaminophen, Gastrointestinal agents
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-602336 (URN)10.1007/s00210-026-05245-5 (DOI)001724347000001 ()41886075 (PubMedID)2-s2.0-105033717288 (Scopus ID)
Forskningsfinansiär
Uppsala UniversityErik, Karin och Gösta Selanders FoundationO.E. och Edla Johanssons vetenskapliga stiftelseSwedish Research Council, 523–2014-2336Swedish Research Council, 2018-0899Swedish Heart Lung Foundation, 20150557Swedish Heart Lung Foundation, 20190310Stockholm County Council, 20140220Karolinska Institute, 2–70/2014
Tilgjengelig fra: 2026-10-29 Laget: 2026-10-29 Sist oppdatert: 2026-10-29bibliografisk kontrollert
Tzioufa, F., Ceylan, M., Di Martino, M. L., Vo, D. S., Lopes, A., Hammar, R., . . . Artursson, P. (2026). Proteomic and functional profiling of suspended jejunal enteroids reveals pharmacokinetic fidelity to native intestine. iScience, 29(10), Article ID 117654.
Åpne denne publikasjonen i ny fane eller vindu >>Proteomic and functional profiling of suspended jejunal enteroids reveals pharmacokinetic fidelity to native intestine
Vise andre…
2026 (engelsk)Inngår i: iScience, E-ISSN 2589-0042, Vol. 29, nr 10, artikkel-id 117654Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Intestinal enteroids are "mini-guts" that recapitulate essential features of the intestinal epithelium in vitro. We developed and characterized native basal-out (BO) and morphogenically everted apical-out (AO) jejunal enteroids cultured in suspension. Using quantitative proteomics and a range of advanced microscopy techniques, we show that these enteroids progressively adopt protein profiles closely resembling those of freshly isolated villus enterocytes and human jejunal tissue. Optimally differentiated enteroids exhibit mature epithelial morphology, intact barrier function, nutrient absorption, and clinically relevant transporter activity (Pglycoprotein; Pgp/ABCB1, breast cancer resistance protein; BCRP/ABCG2), reflecting in vivo physiology. Metabolic assessment of orally administered cytochrome P450 3A4 (CYP3A4) probe drugs, terfenadine and midazolam, accurately predicted first-pass metabolism and clinical pharmacokinetics via physiologically based pharmacokinetic (PBPK) modeling. These findings establish suspension-grown 3D jejunal enteroids as a translationally relevant, human-derived platform that is advantageous over conventional cell line and animal models for studying drug disposition, nutrient transport, and intestinal barrier function.

sted, utgiver, år, opplag, sider
Cell Press, 2026
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-601870 (URN)10.1016/j.isci.2026.117654 (DOI)001894342200001 ()42866664 (PubMedID)2-s2.0-105051912470 (Scopus ID)
Forskningsfinansiär
Swedish Research Council, 2017-02243Swedish Research Council, 2017-01951Swedish Research Council, 2020-05186Swedish Foundation for Strategic Research, FFL18-0165Vinnova, 2019-00048Vinnova, 2024-03851
Tilgjengelig fra: 2026-10-21 Laget: 2026-10-21 Sist oppdatert: 2026-10-21bibliografisk kontrollert
Björner, K., Gulyas, M., Hellström, P. M. & Webb, D.-L. (2026). Tumor–stroma ratio in colitis-associated colorectal cancer. Upsala Journal of Medical Sciences, 130, Article ID e13250.
Åpne denne publikasjonen i ny fane eller vindu >>Tumor–stroma ratio in colitis-associated colorectal cancer
2026 (engelsk)Inngår i: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 130, artikkel-id e13250Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

High stroma content, as measured by tumor-stroma ratio (TSR), is generally a negative prognostic parameter for epithelial cancers, including sporadic colorectal cancer (sCRC). Inflammatory bowel disease patients have higher risk for colorectal cancer than the background population. Evidence suggests that this colitis-associated colorectal cancer (CAC) is more aggressive and occurs at younger age than sCRC. CAC also differs from sCRC in oncogenesis and prognosis. This study tests the hypothesis that TSR in CAC tumors correlates with survival. Age at CAC diagnosis relative to TSR was also explored. TSR was quantified in 36 CAC cases. In routine hematoxylin–eosin staining, the amount of stroma was estimated in categorical steps of 10% increments per image field. The area with highest amount of stroma and tumor tissue at all quadrants of the visual field boundary was scored for TSR. For statistical analysis, tumors were divided into stroma-high (> 50%) or stroma-low (≤ 50%). Of all cases, 22 were stroma-high and 14 were stroma-low. Five-year survival in the stroma-high group was 32% (n = 22), compared to 71% (n = 14) in the stroma-low group (p = 0.049). High stroma content was more frequent if cancer diagnosis was before 60 years of age (17/23) compared to after 60 years of age (5/13). Despite differences in oncogenesis and tumor biology in CAC compared to sCRC, high stroma content also predicts worse outcome in CAC and is particularly common in younger patients.

sted, utgiver, år, opplag, sider
Upsala Medical Society, 2026
HSV kategori
Forskningsprogram
Medicinsk vetenskap
Identifikatorer
urn:nbn:se:uu:diva-580898 (URN)10.48101/ujms.v130.13250 (DOI)001669171100001 ()41503067 (PubMedID)2-s2.0-105026953823 (Scopus ID)
Forskningsfinansiär
Erik, Karin och Gösta Selanders FoundationRegion Uppsala
Tilgjengelig fra: 2026-02-27 Laget: 2026-02-27 Sist oppdatert: 2026-03-20bibliografisk kontrollert
Di Martino, M. L., Jenniches, L., Bhetwal, A., Eriksson, J., Lopes, A. C. C., Ntokaki, A., . . . Sellin, M. E. (2025). A scalable gut epithelial organoid model reveals the genome-wide colonization landscape of a human-adapted pathogen. Nature Genetics, 57(7), 1730-1741
Åpne denne publikasjonen i ny fane eller vindu >>A scalable gut epithelial organoid model reveals the genome-wide colonization landscape of a human-adapted pathogen
Vise andre…
2025 (engelsk)Inngår i: Nature Genetics, ISSN 1061-4036, E-ISSN 1546-1718, Vol. 57, nr 7, s. 1730-1741Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Studying the pathogenesis of human-adapted microorganisms is challenging, since small animal models often fail to recapitulate human physiology. Hence, the comprehensive genetic and regulatory circuits driving the infection process of principal human pathogens such as Shigella flexneri remain to be defined. We combined large-scale Shigella infections of enteroids and colonoids with transposon-directed insertion sequencing and Bayesian statistical modeling to address infection bottlenecks, thereby establishing the comprehensive genome-wide map of Shigella genes required to infect human intestinal epithelium. This revealed the Shigella virulence effectors essential for epithelial cell colonization across geometries and intestinal segments, identified over 100 chromosomal genes involved in the process and uncovered a post-transcriptional mechanism whereby tRNA-modification enzymes and differential codon usage exert global control of a bacterial virulence program. Our findings provide a broadly applicable framework for combining advanced organotypic tissue culture with functional genomics and computational tools to map human–microorganism interactions at scale.

sted, utgiver, år, opplag, sider
Springer Nature, 2025
HSV kategori
Forskningsprogram
Medicinsk vetenskap
Identifikatorer
urn:nbn:se:uu:diva-559435 (URN)10.1038/s41588-025-02218-x (DOI)001507505400001 ()40506541 (PubMedID)2-s2.0-105007891853 (Scopus ID)
Tilgjengelig fra: 2025-06-13 Laget: 2025-06-13 Sist oppdatert: 2026-09-02bibliografisk kontrollert
Geiser, P., Di Martino, M. L., Lopes, A. C. C., Bergholtz, A., Sundbom, M., Skogar, M., . . . Sellin, M. E. (2025). Determinants of divergent Salmonella and Shigella epithelial colonization strategies resolved in human enteroids and colonoids. mBio, 16(7), 1-22
Åpne denne publikasjonen i ny fane eller vindu >>Determinants of divergent Salmonella and Shigella epithelial colonization strategies resolved in human enteroids and colonoids
Vise andre…
2025 (engelsk)Inngår i: mBio, ISSN 2161-2129, E-ISSN 2150-7511, Vol. 16, nr 7, s. 1-22Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Despite their relatedness, Salmonella and Shigella enteropathogens differ in infectious dose, pathogenesis, and disease kinetics. The prototype strains Salmonella enterica serovar Typhimurium (Salmonella) and Shigella flexneri (Shigella) use Type-3-secretion-systems (T3SSs) to colonize intestinal epithelial cells (IECs). However, they have evolved unique sets of T3SS effectors and accessory virulence factors. A synthesis of how these differences impact the temporal progression of infection in non-transformed human epithelia is missing. Here, we followed Salmonella and Shigella infections of human enteroids and colonoids by time-lapse imaging to pinpoint virulence factor modules that shape the divergent epithelial colonization strategies. By an apical targeting module that integrates flagella and the SPI-4-encoded adhesin system with T3SS-1, Salmonella accomplishes appreciable numbers of apical IEC invasion events. These are promptly counteracted by IEC death, thus fostering a polyclonal iterative epithelial colonization strategy. The lack of a corresponding apical targeting module in Shigella makes this pathogen reliant on external factors, for example, preexisting damage, for rare apical access to the intraepithelial environment. However, Shigella compensates for this ineptness by an intraepithelial expansion module reliant on the tight coupling of OspC3-dependent temporal delay of cell death and IcsA-mediated mobility. This module enables intraepithelial Shigella to evade the IEC death response just long enough to expand laterally, thus fostering an essentially monoclonal colonization strategy. Taken together, the study reveals how a small set of virulence factors shapes divergent epithelial colonization strategies by related enterobacteria.

sted, utgiver, år, opplag, sider
American Society for Microbiology, 2025
Emneord
Salmonella, Shigella, enteroids, colonoids, invasion, inflammasome, cell death
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-539496 (URN)10.1128/mbio.00911-25 (DOI)001499028100001 ()40444467 (PubMedID)2-s2.0-105010951969 (Scopus ID)
Merknad

Authors in the list of paper of Petra Geiser's thesis: Geiser, P., Di Martino, M. L., Lopes, A. C. C., Bergholtz, A., Sundbom, M., Skogar, M., Graf, W., Webb, D.-L., Hellström, P. M., Eriksson, J., Sellin, M. E.

Tilgjengelig fra: 2024-10-01 Laget: 2024-10-01 Sist oppdatert: 2025-09-09bibliografisk kontrollert
Javidi, D., Webb, D.-L., Diaz, H. O., Ud-din, M., Elias, K., Sundbom, M. & Hellström, P. M. (2025). Differential Gastric Motility, Gut Hormone, and Appetite Changes Following A Mixed Meal in People With Obesity and Healthy Controls. Neurogastroenterology and Motility, 37(11), Article ID e70163.
Åpne denne publikasjonen i ny fane eller vindu >>Differential Gastric Motility, Gut Hormone, and Appetite Changes Following A Mixed Meal in People With Obesity and Healthy Controls
Vise andre…
2025 (engelsk)Inngår i: Neurogastroenterology and Motility, ISSN 1350-1925, E-ISSN 1365-2982, Vol. 37, nr 11, artikkel-id e70163Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Introduction

Understanding meal-induced changes of gut hormones, gastric motility, and appetite is crucial for developing therapies for obesity. We investigated glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), ghrelin, and motilin influences on gastric motility and appetite, to compare healthy individuals and people with obesity.

Methods

Subjects (healthy n = 41; obesity n = 32) consumed a 270-kcal meal and a wireless motility capsule. GIP, active GLP-1, acyl-ghrelin, and motilin were measured by electrochemiluminescence. MotiliGI and GIMS software were used for motility analysis, while visual analog scoring measured appetite.

Results

Gastric emptying was more rapid in people with obesity than in healthy individuals (p < 0.01). Gastric emptying time was negatively associated with motility index and hunger contractions (p < 0.01, p < 0.05) in healthy individuals, but not in individuals with obesity. In controls, gastric motility index correlated positively with acyl-ghrelin (p < 0.01) and motilin (p < 0.0001), and negatively with GIP (p < 0.05), but not aGLP-1. In people with obesity, no gut hormones correlated with the motility index. In both groups, GIP and aGLP-1 correlated with decreased hunger (p < 0.0001, p = 0.001) and (p < 0.0001, p < 0.05), along with increased satiety in controls (p < 0.0001, p = 0.001) and people with obesity (p = 0.049, p = 0.01). Acyl-ghrelin correlated positively with hunger (p < 0.0001) and negatively with satiety (p = 0.049) in controls, but not in obesity. Motilin was neither associated with hunger nor satiety.

Conclusion

In the gastric phase, people with obesity show rapid gastric emptying with altered hormone and motility meal responses. In healthy individuals, GIP promotes satiety, and ghrelin and motilin promote hunger through actions on motility. Like GIP, GLP-1 promotes satiety along with trending suppression of gastric motility.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2025
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-568426 (URN)10.1111/nmo.70163 (DOI)001574279300001 ()40961390 (PubMedID)2-s2.0-105016471969 (Scopus ID)
Tilgjengelig fra: 2025-10-13 Laget: 2025-10-13 Sist oppdatert: 2026-06-22bibliografisk kontrollert
van Rijn, j., Lopes, A., Ceylan, M., Eriksson, J., Bergholtz, A., Ntokaki, A., . . . Sellin, M. E. (2025). Maturation of Human Intestinal Epithelial Cell Layers Fortifies the Apical Surface against Salmonella Attack. Cell Reports, 44(12), Article ID 116579.
Åpne denne publikasjonen i ny fane eller vindu >>Maturation of Human Intestinal Epithelial Cell Layers Fortifies the Apical Surface against Salmonella Attack
Vise andre…
2025 (engelsk)Inngår i: Cell Reports, ISSN 2639-1856, E-ISSN 2211-1247, Vol. 44, nr 12, artikkel-id 116579Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Pathogen invasion of intestinal epithelial cells (IECs) is a key gut infection event. The dynamics of this process in intact epithelia and the factors governing IEC susceptibility remain underexplored. We present a resource for live-cell infection imaging in human enteroid-/colonoid-derived IEC layers across maturation states and in the presence or absence of soluble mucus production. Utilization of this resource shows how human IEC maturation fortifies the apical surface against invasion by Salmonella Typhimurium (S.Tm). Immature IEC layers appear permissive to S.Tm invasion, but maturation toward an enterocyte/colonocyte phenotype reduces the susceptibility by up to 10-fold. This shift couples to downregulated expression of actin regulatory proteins exploited by the pathogen, an increased dependence on the S.Tm effector SipA, and the build-up of the apical IEC glycocalyx linked to surface-attached mucins like MUC13 and nullifiable by StcE-enzyme treatment. This underscores how the maturation state of human IECs governs susceptibility to bacterial invasion.

sted, utgiver, år, opplag, sider
Elsevier, 2025
Emneord
Intestinal epithelium, Epithelial cell, Differentiation, Organoid, Infection, Live-cell imaging, Salmonella, Mucin, Brush border, Glycocalyx
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-551249 (URN)10.1016/j.celrep.2025.116579 (DOI)001674052300001 ()41275500 (PubMedID)2-s2.0-105025661792 (Scopus ID)
Forskningsfinansiär
Swedish Research Council, 2017-01951Swedish Research Council, 2020-01586Swedish Research Council, 2018-02223Swedish Research Council, 2022-01590Swedish Foundation for Strategic Research, FFL18-0165EU, Horizon 2020, 101119504
Tilgjengelig fra: 2025-02-22 Laget: 2025-02-22 Sist oppdatert: 2026-03-17bibliografisk kontrollert
Åberg, S., Webb, D.-L., Nordin, E., Hellström, P. M. & Landberg, R. (2025). Postprandial Effects of Four Test Meals Containing Wholegrain Rye or Refined Wheat Foods on Circulating Incretins, Ghrelin, Glucose, and Inflammatory Markers. Journal of Nutrition, 155(1), 185-196
Åpne denne publikasjonen i ny fane eller vindu >>Postprandial Effects of Four Test Meals Containing Wholegrain Rye or Refined Wheat Foods on Circulating Incretins, Ghrelin, Glucose, and Inflammatory Markers
Vise andre…
2025 (engelsk)Inngår i: Journal of Nutrition, ISSN 0022-3166, E-ISSN 1541-6100, Vol. 155, nr 1, s. 185-196Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background

High intake of whole grains has consistently been associated with reduced risk of obesity, coronary artery disease, and type 2 diabetes. Dietary interventions have shown beneficial metabolic effects of whole grains, but the metabolic response varies with different types of cereals.

Objectives

We evaluate the metabolic effects of substituting refined wheat with wholegrain rye foods within a complex diet, examining the day-long postprandial response of glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), ghrelin, glucose, and inflammatory biomarkers in individuals with overweight and obesity.

Methods

Twenty-nine healthy adults with body mass index of 32 ± 9 kg/m2 were randomly assigned to 3 intervention days, separated by 1-wk washout. Participants adhered to a hypocaloric diet rich in wholegrain rye for 1 intervention and refined wheat for the second intervention and were randomly assigned to either diet for the third intervention with continuous blood sampling.

Results

No differences in GIP, GLP-1, or ghrelin levels were found between the diets when measured throughout the whole intervention day. GIP total area under the curve after the rye-based lunch was 31% (P < 0.05) lower compared with the wheat-based lunch, and ghrelin concentrations were 29% (P < 0.05) lower after the rye-based dinner. Baseline Homeostatic Model Assessment for Insulin Resistance-adjusted model showed 61% (P = 0.015) lower whole-day GLP-1 and 40% (P = 0.03) lower GIP after the rye-based diet. Day-long glucose incremental area under the curve was 30% (P < 0.001) lower after the rye-based diet, and glycemic variability was measured as SD reduced (−0.13 mmol/L, P = 0.04). The rye-based diet compared with refined wheat induced higher glycoprotein N-acetylation A, as measured by z-scores (0.36, P = 0.014).

Conclusions

Overall, no day-long differences in gut hormone levels were observed, but the wholegrain rye-based compared with refined wheat-based dinner showed lower postprandial ghrelin concentrations. The rye-based diet improved day-long glycemic control in individuals with overweight and obesity. Observations of diet-induced inflammation after whole-grain rye intake warrant further investigation.

Trial registration number

This study was registered at Clinical Trials Registry of clinicaltrials.gov (NCT05004584): https://clinicaltrials.gov/study/NCT05004584?locStr=Gothenburg,%20Sweden&country=Sweden&state=V%C3%A4stra%20G%C3%B6taland%20County&city=Gothenburg&distance=50&term=appetite&aggFilters=status:com&rank=1

sted, utgiver, år, opplag, sider
Elsevier, 2025
Emneord
wholegrain rye, obesity, overweight, continuous glucose, ghrelin, incretin, appetite regulation, postprandial glucose, postprandial incretin, clinical trial
HSV kategori
Identifikatorer
urn:nbn:se:uu:diva-548683 (URN)10.1016/j.tjnut.2024.10.046 (DOI)001412964500001 ()39515756 (PubMedID)2-s2.0-85210722253 (Scopus ID)
Forskningsfinansiär
Swedish Research Council Formas, 00542-2014Swedish Research Council, 2017-05840
Tilgjengelig fra: 2025-01-28 Laget: 2025-01-28 Sist oppdatert: 2025-02-25bibliografisk kontrollert
Erhardsson, M., Faxén, U. L., Venkateshvaran, A., Hage, C., Pironti, G., Thorvaldsen, T., . . . Lund, L. H. (2024). Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure. ESC Heart Failure, 11(1), 601-605
Åpne denne publikasjonen i ny fane eller vindu >>Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure
Vise andre…
2024 (engelsk)Inngår i: ESC Heart Failure, E-ISSN 2055-5822, Vol. 11, nr 1, s. 601-605Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

AIM: Acyl ghrelin increases cardiac output (CO) in heart failure with reduced ejection fraction (HFrEF). This could impair the right ventricular-pulmonary arterial coupling (RVPAC), both through an increased venous return and right ventricular afterload. We aim to investigate if acyl ghrelin increases CO with or without worsening the right-sided haemodynamics in HFrEF assessed by RVPAC.

METHODS AND RESULTS: The Karolinska Acyl ghrelin Trial was a randomized double-blind placebo-controlled trial of acyl ghrelin versus placebo (120-min intravenous infusion) in HFrEF. RVPAC was assessed echocardiographically at baseline and 120 min. ANOVA was used for difference in change between acyl ghrelin versus placebo, adjusted for baseline values. Of the 30 randomized patients, 22 had available RVPAC (acyl ghrelin n = 12, placebo n = 10). Despite a 15% increase in CO in the acyl ghrelin group (from 4.0 (3.5-4.6) to 4.6 (3.9-6.1) L/min, P = 0.003), RVPAC remained unchanged; 5.9 (5.3-7.6) to 6.3 (4.8-7.5) mm·(m/s)-1 , P = 0.372, while RVPAC was reduced in the placebo group, 5.2 (4.3-6.4) to 4.8 (4.2-5.8) mm·(m/s)-1 , P = 0.035. Comparing change between groups, CO increased in the acyl ghrelin group versus placebo (P = 0.036) while RVPAC and the right ventricular pressure gradient remained unchanged.

CONCLUSION: Treatment with acyl ghrelin increases CO while preserving or even improving RVPAC in HFrEF, possibly due to increased contractility, reduced PVR and/or reduced left sided filling pressures. These potential effects strengthen the role of acyl ghrelin therapy in HFrEF with right ventricular failure.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2024
Emneord
Acyl ghrelin, Heart failure, Inotrope
HSV kategori
Forskningsprogram
Kardiologi
Identifikatorer
urn:nbn:se:uu:diva-517116 (URN)10.1002/ehf2.14580 (DOI)001118122700001 ()38030138 (PubMedID)2-s2.0-85178196889 (Scopus ID)
Forskningsfinansiär
Swedish Research Council, 523-2014-2336Swedish Heart Lung Foundation, 20150557Swedish Heart Lung Foundation, 20190310Karolinska Institute, 2-70/2014Stockholm County Council, 20140220Swedish Research Council, 20180899
Tilgjengelig fra: 2023-12-04 Laget: 2023-12-04 Sist oppdatert: 2025-02-21bibliografisk kontrollert
Lund, L. H., Hage, C., Pironti, G., Thorvaldsen, T., Ljung-Faxén, U., Zabarovskaja, S., . . . Ståhlberg, M. (2023). Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization. European Heart Journal, 44(22), 2009-2025
Åpne denne publikasjonen i ny fane eller vindu >>Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization
Vise andre…
2023 (engelsk)Inngår i: European Heart Journal, ISSN 0195-668X, E-ISSN 1522-9645, Vol. 44, nr 22, s. 2009-2025Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background and Aims

Ghrelin is an endogenous appetite-stimulating peptide hormone with potential cardiovascular benefits. Effects of acylated (activated) ghrelin were assessed in patients with heart failure and reduced ejection fraction (HFrEF) and in ex vivo mouse cardiomyocytes.

Methods and results

In a randomized placebo-controlled double-blind trial, 31 patients with chronic HFrEF were randomized to synthetic human acyl ghrelin (0.1 µg/kg/min) or placebo intravenously over 120 min. The primary outcome was change in cardiac output (CO). Isolated mouse cardiomyocytes were treated with acyl ghrelin and fractional shortening and calcium transients were assessed. Acyl ghrelin but not placebo increased cardiac output (acyl ghrelin: 4.08 ± 1.15 to 5.23 ± 1.98 L/min; placebo: 4.26 ± 1.23 to 4.11 ± 1.99 L/min, P < 0.001). Acyl ghrelin caused a significant increase in stroke volume and nominal increases in left ventricular ejection fraction and segmental longitudinal strain and tricuspid annular plane systolic excursion. There were no effects on blood pressure, arrhythmias, or ischaemia. Heart rate decreased nominally (acyl ghrelin: 71 ± 11 to 67 ± 11  b.p.m.; placebo 69 ± 8 to 68 ± 10  b.p.m.). In cardiomyocytes, acyl ghrelin increased fractional shortening, did not affect cellular Ca2+ transients, and reduced troponin I phosphorylation. The increase in fractional shortening and reduction in troponin I phosphorylation was blocked by the acyl ghrelin antagonist D-Lys 3.

Conclusion

In patients with HFrEF, acyl ghrelin increased cardiac output without causing hypotension, tachycardia, arrhythmia, or ischaemia. In isolated cardiomyocytes, acyl ghrelin increased contractility independently of preload and afterload and without Ca2+ mobilization, which may explain the lack of clinical side effects. Ghrelin treatment should be explored in additional randomized trials.

sted, utgiver, år, opplag, sider
Oxford University Press, 2023
Emneord
Heart failure, Contractility, Fractional shortening, Cardiac output, Stroke volume, Inotrope, Myotrope, Ghrelin, Acyl ghrelin, Acylated ghrelin, Calcium
HSV kategori
Forskningsprogram
Medicinsk vetenskap
Identifikatorer
urn:nbn:se:uu:diva-501845 (URN)10.1093/eurheartj/ehad100 (DOI)000949868200001 ()36916707 (PubMedID)2-s2.0-85162144227 (Scopus ID)
Forskningsfinansiär
Swedish Research Council, 523-2014-2336Karolinska Institute, 2-70/2014Swedish Society for Medical Research (SSMF)Harald and Greta Jeansson FoundationSwedish Heart Lung Foundation, 20150557Swedish Heart Lung Foundation, 20190310Region Stockholm, 20140220Swedish Research Council, 20180899
Tilgjengelig fra: 2023-05-16 Laget: 2023-05-16 Sist oppdatert: 2026-01-22bibliografisk kontrollert
Organisasjoner
Identifikatorer
ORCID-id: ORCID iD iconorcid.org/0000-0002-6979-9194